On the loss of the phosphorylcholine-based DES coating on the abluminal surface of endeavor stents

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 1, 2010, Pages 158-159

  Von Birgelen, Clemens ^a,b   Basalus, Mounir W Z ^a  

^a Department of Cardiology Thoraxcentrum Twente ^*  (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORYLCHOLINE; BIOMATERIAL;

DIABETES MELLITUS; DRUG ELUTING STENT; HEART INJURY; HIGH RISK PATIENT; HUMAN; LETTER; MATERIAL COATING; TREATMENT FAILURE; CORONARY ARTERY DISEASE; DEVICES; PROSTHESIS; PROSTHESIS FAILURE; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; PHOSPHORYLCHOLINE; PROSTHESIS DESIGN; PROSTHESIS FAILURE; SURFACE PROPERTIES; TREATMENT FAILURE;

EID: 77954102272     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22497     Document Type: Letter

References (6)

1. Wiemer M, Butz T, Schmidt W, Schmitz KP, Horstkotte D, Langer C. Scanning electron microscopic analysis of different drug-eluting stents after failed implantation: From nearly undamaged to major damaged polymer. Cathet Cardiovasc Interv, in press; DOI 10.1002/ccd. 21373.
2. Ormiston JA, Webster M, Ruygrok P. Polymer integrity after Cypher and Taxus stent implantation: A scanning electron microscope study. Presented at TCT, Washington, D.C., 2004; Available at: http://www. tctmd.com.
3. Otsuka Y, Chronos NA, Apkarian RP, Robinson KA. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents. J Invasive Cardiol 2007;19:71-76.
4. Basalus MW, Ankone MJ, van Houwelingen GK, de Man FH, von Birgelen C. Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. EuroInterv 2009;5:157-165.
5. Leon MB. Endeavor IV-A randomized comparison of a zotarolimus-eluting stent endeavor IV-A randomized comparison of a zotarolimus-eluting stent. Presented at TCT, Washington, D.C., 2007; Available at: http://www.tctmd.com.
6. Kirtane AJ, Patel R, O'Shaughnessy C, Overlie P, McLaurin B, Solomon S, Mauri L, Fitzgerald P, Popma JJ, Kandzari DE, Leon MB. Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: Randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc Interv 2009;2:967-976.